23/01/07 - Trials
Daval International Limited now has links with a number of key clinical and scientific researchers worldwide, with a growing level of interest being shown in the setting up of randomised double-blind, placebo controlled clinical trials of AIMSPRO. A European leader in the study and treatment of multiple sclerosis has recently submitted a trial protocol for consideration by an Institutional Ethics Committee and the Competent Authority. This long term study will focus on bladder symptoms in secondary progressive multiple sclerosis.
If approval is achieved from these two entities than announcements for recruitment of patients will be made by MS charity groups. In addition, updated trials information will be regularly posted on this web site.
- Similar Topics
- Last post